Shuchi Nahar's Weekend Blog!

Indian Pharmaceutical Industry Outlook Shuchi.P.Nahar The pharmaceutical sector is at a crossroads. In a heavily disrupted marketplace, characterized by shifting payer attitudes and patient empowerment, neither incremental adjustments nor steady evolution are likely to halt the decline of the traditional pharmaceutical business model. This paper looks ahead to a 2030 scenario to examine the trends revolutionizing the sector trends that we expect to have dramatic impacts.  The Indian pharmaceutical industry has contributed immensely not just to Indian but to global healthcare outcomes. India continues to play a material role in manufacturing various critical, high‐ quality and low‐cost medicines for Indian and global markets. It supplies 50 to 60 % of global demand for many vaccines (including ARVs), 40 % of generics consumed in the US and 25 percent of all the medicines dispensed in the UK . Over the last 5 years, 35 to 38 % of total ANDAs approved (including 25 to 30 pe...

Weekend BLOG 4                                                                                                      Shuchi.P.Nahar Disclaimer: So in this blog I have tried to summarize my learning from various research reports justifying the road map for pharma companies in India. All credits to content writers and various reports that are worth reading to have an extra-ordinary idea about pharma sector growth and expansion ahead. Pharma Sector Growth Ahead-2020 The Indian pharmaceuticals market has characteristics that make it unique.  First, branded generics dominate, making up for 70 to 80 per cent of the retail market.  Second, local players have enjoyed a dominant position driven by formulation development c...